um_svilab Profile Banner
UM SVI LAB Profile
UM SVI LAB

@um_svilab

Followers
75
Following
53
Media
2
Statuses
40

University of Miami Brain Tumor Initiative Section of Virology and Immunology Pioneering Translational Therapies for Brain Tumor

Univeristy of Miami
Joined October 2022
Don't wanna be here? Send us removal request.
@um_svilab
UM SVI LAB
5 months
We're proud of our MD-PhD trainee, Christian Ramsoomair , for attending the ChadTough Defeat DIPG Workshop, uniting global experts to advance DIPG research. His participation reflects SVI Lab's commitment to defeating childhood brain cancer through collaboration and innovation.
1
2
8
@AshishHShah4
Ashish H. Shah
6 months
Grateful for this dream job to tackle brain tumors using viral/immunotx! Thank you to my colleagues and chair for their unwavering support as we continue the fight against brain cancer @AllanLeviMD @michaelivanmd @Ricardokomotar @delaFuenteNOnc @UMneurosurgery @SylvesterCancer
@SylvesterCancer
Sylvester Comprehensive Cancer Center
6 months
Meet Dr. @AshishHShah4, whether in the operating room treating brain tumor patients or in the lab developing next-gen therapies, Dr. Shah is pushing boundaries in brain cancer care. Discover how evolutionary biology is fueling Dr. Shah's leading-edge research:
7
7
72
@um_svilab
UM SVI LAB
7 months
Congrats @CKRamsoomair! Excited for your talk at @AANSNeuro!
@CKRamsoomair
Christian K Ramsoomair
7 months
Excited for the opportunity to give an oral presentation on Neurosurgical Leadership in Neuro-Oncology Clinical Trials at this year’s @AANSNeuro Annual Meeting in Boston! @AshishHShah4 @umiamimedicine @UMneurosurgery
0
1
6
@SylvesterCancer
Sylvester Comprehensive Cancer Center
8 months
🔬 #Glioblastoma is the most common brain tumor in adults, yet treatment progress has stalled for 20 years. Dr. @AshishHShah4’s new study at Sylvester identifies ZNF638 as a key target to boost immune response and improve #immunotherapy for glioblastoma. 🙌 https://t.co/g6hw3hS7f7
Tweet card summary image
news.med.miami.edu
New research from Sylvester scientists has found that targeting a “master regulator” protein can induce an antiviral glioblastoma response.
0
2
11
@AshishHShah4
Ashish H. Shah
8 months
Thrilled to share our @um_svilab work published today in @jclinicalinvest focused on harnessing viral mimicry to activate immunotherapy for #GBM. Thanks to all of my @SylvesterCancer @UMneurosurgery colleagues for their invaluable contributions! https://t.co/nB4bcsFuFc
4
13
71
@AshishHShah4
Ashish H. Shah
8 months
Excited about this inaugural tumor section event at the AANS! @NSTumorSection @hadjiMDPhD @chandraankush @UMneurosurgery @jacquesmorcosmd
@AANSNeuro
AANS
8 months
Join us for the Inaugural Tumor Soirée hosted by the @NSTumorSection ECNC at AANS Boston. An evening of insightful case discussions, networking and fine dining. Limited spots are available, sign up now! 🍽️🧠 #AANS2025 #TumorSoiree https://t.co/O9fb6EftJG
0
5
16
@AshishHShah4
Ashish H. Shah
9 months
Amazing meeting @southernneuro in Marco Island! Thoroughly enjoyed all the research presentations and lectures! Great line up and program @StephenPirrisMD @spirosblackburn @UTHNeuro @UMneurosurgery @SylvesterCancer Thanks for having us present our work! @um_svilab
0
1
17
@AshishHShah4
Ashish H. Shah
2 years
Congrats to @um_svilab alum @MynorMendez_ on his match at OSU! You have great leadership with @RussellLonser and fantastic faculty to train with. Great things to come ahead for you! Looking forward to watching your neurosurgical career blossom!
@MynorMendez_
Mynor Mendez
2 years
Honored to have the opportunity to train at one of the best neurosurgery residency programs in the country. Couldn’t have done this without the support of @AshishHShah4 and the entire @UMneurosurgery department. Excited for the next step in the journey!
0
1
12
@AshishHShah4
Ashish H. Shah
2 years
Looking to hire a research associate for our lab at the University of Miami in May (2 yr commitment)! Exciting opportunity to study viral oncology/immunotherapy for brain tumors. Basic/Bioinformatic experience is welcomed! Please reach out via our website https://t.co/0aFHkMo18H
shahlab.squarespace.com
Section of Virology and Immunotherapy
0
5
24
@AshishHShah4
Ashish H. Shah
2 years
Getting ready for clinical trials using virotherapy requires optimization of your protocols! Yesterday we found our patient @Publix ! Mr. Melon recovered well from robotic neurosurgery :) #publix #CED @ROSArobot @UMneurosurgery
3
2
59
@AshishHShah4
Ashish H. Shah
2 years
Congrats to @um_svilab member @CKRamsoomair for being selected as a Frost Institute for Data Science and Computing Fellow! Excited to see how this program will bridge boundaries between disciplines! @umiamimedicine #DataScience
1
2
16
@AshishHShah4
Ashish H. Shah
2 years
@um_svilab Lab happy hour @VezaSur ! Missing a few members of the team but glad we were able to get a breather from the 🐁 🧠 🔪 and 🔬. #blessed #nodramalab #btsm @jaychandar5 @SeetharamDeepa
0
2
8
@AshishHShah4
Ashish H. Shah
2 years
LITT induces a robust immune response for GBM. Here we show ~10 year survival for IDHwt GBM after LITT for nGBM. Congrats @jaychandar5 @um_svilab for work demonstrating the local changes in the GBM TME w/ LITT and RT with inc. PD-L1 and CD8 infiltration in J. of Immunotherapy.
3
11
81
@AshishHShah4
Ashish H. Shah
2 years
What happens when dormant oncogenic retroviruses are reactivated in astroglia? Thanks @NINDSnews /Nath lab for capturing this beautiful transformation for our recent JCI pub! @SylvesterCancer @um_svilab Apologies re: poor quality GIF. Full video ��️ https://t.co/fvv0vA3pZD
1
3
18
@AshishHShah4
Ashish H. Shah
2 years
@TaylorJ_MD
Taylor Lab UM
2 years
Congrats to PhD Candidate Ray Castro for passing his Qualifying Exam today🎉! Ray's exciting project on Investigating Novel Targets in #Glioblastoma takes advantage of our @SylvesterCancer Brain Tumor Initiative and Drug Discovery resources. Co-mentored with @AshishHShah4 lab.
0
2
22
@jclinicalinvest
Journal of Clinical Investigation
2 years
Human endogenous retrovirus-K maintains the cancer-stem cell phenotype in glioblastoma: https://t.co/9WyV8GH94S @ashishshahmd4 @umsvilab @NINDS #StemCells #Virology
1
3
13
@AshishHShah4
Ashish H. Shah
2 years
Thank you @SylvesterCancer and @NINDSnews for their unwavering support for our study investigating the role of HERV-K in the GBM cancer stem-cell niche. Thank you to my colleagues and mentors Avi, John Heiss and @MRGneuroonc for their support ! We’re just getting to work!
@SylvesterCancer
Sylvester Comprehensive Cancer Center
2 years
A five- to six-million-year-old retrovirus drives #glioblastoma, says Sylvester researcher @AshishHShah4, lead author of a published study on human endogenous retrovirus-K. Read more about the published study: https://t.co/Vw8qn4aOC7
2
2
38
@AshishHShah4
Ashish H. Shah
2 years
Super excited about this collaboration and the fact that I got to wear @JustinLathia success chain! @UMneurosurgery @SylvesterCancer @d_bayik
@d_bayik
Defne Bayik
2 years
Celebrating our first collaborative grant w/ @AshishHShah4 in true Miami fashion: the success chain ⛓️, colada ☕️ and a joint lab meeting w/ @Oyt4Teran as the presenter 👩‍🔬👩‍💻�� just the beginning of a long, productive scientific partnership! 💪🧫🧬🔬#glioblastoma #immunotherapy
1
3
24
@d_bayik
Defne Bayik
2 years
Celebrating our first collaborative grant w/ @AshishHShah4 in true Miami fashion: the success chain ⛓️, colada ☕️ and a joint lab meeting w/ @Oyt4Teran as the presenter 👩‍🔬👩‍💻… just the beginning of a long, productive scientific partnership! 💪🧫🧬🔬#glioblastoma #immunotherapy
2
2
60